⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ARTV News
Artiva Biotherapeutics, Inc. Common Stock
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
prnewswire.com
GTBP
ARTV
FATE
IBRX
CHRS
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
ARTV
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
ARTV
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
globenewswire.com
ARTV
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
ARTV
Liberty All-Star® Growth Fund, Inc. February 2026 Monthly Update
businesswire.com
NVDA
AAPL
GOOGL
MSFT
META
AMZN
CW
OLLI
AVGO
LGN
MPWR
ARTV
ASND
LLY
NVT
CAT
FTAI
LOW
PLTR
TKO
PINS
UNH
Form 8-K
sec.gov
ARTV
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
globenewswire.com
ARTV